American International Group’s Summit Therapeutics SMMT Stock Holding History

American International Group’s Portfolio SMMT Stock Details SMMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-57,108	Closed	-$236K	–	2315
2024 Q1	$236K	Sell	57,108 -490	-0.9%	-$1.95K	﹤0.01%	2055
2023 Q4	$150K	Sell	57,598 -233	-0.4%	-$479	﹤0.01%	2327
2023 Q3	$108K	Buy	57,831 +2,056	+4%	+$3.92K	﹤0.01%	2470
2023 Q2	$140K	Buy	+55,775	New	+$102K	﹤0.01%	2370
2022 Q2	–	Sell	-13,087	Closed	-$32K	–	3246
2022 Q1	$32K	Sell	13,087 -920	-7%	-$2.32K	﹤0.01%	2966
2021 Q4	$38K	Sell	14,007 -419	-3%	-$2.01K	﹤0.01%	3022
2021 Q3	$72K	Buy	14,426 +1,831	+15%	+$13.1K	﹤0.01%	2915
2021 Q2	$94	Buy	+12,595	New	+$82.6K	﹤0.01%	2888

Other funds holding SMMT

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

American International Group's SMMT Position: Q2 2024 in Review

American International Group sold out of Summit Therapeutics (SMMT) in Q2 2024, closing a stake of 57,108 shares — an estimated $236K sold.

American International Group first reported a position in SMMT in Q2 2021 and held it in 8 quarters. The position peaked at $236K in Q1 2024. 123 funds tracked by Wall St. Rank hold SMMT as of Q2 2024.

American International Group reported no remaining Summit Therapeutics position as of Q2 2024 after selling out during the quarter.
American International Group sold 57,108 Summit Therapeutics shares in Q2 2024, an estimated $236K.
American International Group first reported a position in Summit Therapeutics in Q2 2021 and held it in 8 quarters.
American International Group's Summit Therapeutics position peaked at $236K in Q1 2024.
123 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.